Results 271 to 280 of about 171,911 (304)

The Importance of Serum Perilipin-2 Level as an Early Indicator of Inflammation in Non-Alcoholic Fatty Liver Disease. [PDF]

open access: yesDiagnostics (Basel)
Alpaydin OV   +8 more
europepmc   +1 more source

Non-alcoholic fatty liver disease

Scandinavian Journal of Gastroenterology, 2007
Non-alcoholic fatty liver disease (NAFLD) affects a substantial proportion of the population and has a close association with insulin resistance.
Einar, Björnsson, Paul, Angulo
openaire   +2 more sources

Non‐alcoholic fatty liver disease

Journal of Gastroenterology and Hepatology, 2002
AbstractNon‐alcoholic fatty liver disease (NAFLD) is a chronic liver disease that affects a high proportion of the world’s population. Insulin resistance and oxidative stress play a critical role in the pathogenesis of NAFLD. Clinical, biochemical and imaging studies are of value in the diagnostic evaluation of patients with NAFLD, but liver biopsy ...
Paul, Angulo, Keith D, Lindor
openaire   +2 more sources

Non-alcoholic fatty liver disease

British Journal of Hospital Medicine, 2005
This article reviews the nomenclature, clinical and histological basis for a diagnosis of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis, its natural history, pathophysiology and an approach to clinical management.
Ian Homer Y, Cua, Jacob, George
openaire   +2 more sources

Non-alcoholic fatty liver disease

Critical Reviews in Clinical Laboratory Sciences, 2011
Non-alcoholic fatty liver disease (NAFLD) refers to the accumulation of hepatic steatosis not due to excess alcohol consumption. The prevalence of NAFLD is up to 30% in developed countries and nearly 10% in developing nations, making NAFLD the most common liver condition in the world. The pathogenesis of NAFLD is related to insulin resistance and, thus,
Briohny W, Smith, Leon A, Adams
openaire   +2 more sources

Non-alcoholic fatty liver disease in pregnancy

Obstetric Medicine, 2021
Non-alcoholic fatty liver disease (NAFLD) is now the commonest liver pathology in the UK; however, relatively little is known about its course in pregnancy or the effect it has on maternal or fetal outcomes. Described here is a 24-year-old woman in her first pregnancy who presented with non-specific symptoms and raised alanine aminotransferase with ...
Charlotte S Benson   +2 more
openaire   +2 more sources

Epidemiology of Non-Alcoholic Fatty Liver Disease

Digestive Diseases, 2010
Non-alcoholic fatty liver disease (NAFLD) is rapidly becoming the most common liver disease worldwide. The prevalence of NAFLD in the general population of Western countries is 20–30%. About 2–3% of the general population is estimated to have non-alcoholic steatohepatitis (NASH), which may progress to liver cirrhosis and hepatocarcinoma. As a rule, the
Bellentani S.   +3 more
openaire   +2 more sources

Liver transplantation for non-alcoholic fatty liver disease

Minerva Gastroenterology, 2018
Non-alcoholic fatty liver disease (NAFLD) is considered the hepatic manifestation of metabolic syndrome, and it is defined by the presence of steatosis in >5% of hepatocytes, according to histological analysis or detected by specific proton density fat fraction obtained magnetic resonance imaging.
Giacomo, Germani, Chiara, Becchetti
openaire   +2 more sources

Non-alcoholic fatty liver disease

Nursing Standard, 2016
Essential facts Non-alcoholic fatty liver disease (NAFLD) is an excess of fat in the liver that is not the result of excessive alcohol consumption or other secondary causes, such as hepatitis C. According to the National Institute for Health and Care Excellence, fatty liver - steatosis - affects between 20% and 30% of the population and its prevalence ...
openaire   +2 more sources

Home - About - Disclaimer - Privacy